|
Gender (male/female)
|
1.128 (0.602-2.115)
|
0.707
| | |
|
Age (years) (≤51/>51)
|
2.305 (1.525-3.484)
|
<0.001
|
3.570 (2.311-5.516)
|
<0.001
|
|
Serum HBsAg (negative/positive)
|
0.822 (0.556-1.215)
|
0.326
| | |
|
Serum AFP (ng/ml) (≤20/>20)
|
0.945 (0.645-1.384)
|
0.772
| | |
|
Tumor size (cm) (≤5/>5)
|
1.410 (0.958-2.077)
|
0.082
| | |
|
Tumor number (single/multiple)
|
2.250 (1.422-3.559)
|
0.001
|
1.149 (0.300-4.403)
|
0.839
|
|
Tumor differentiation (I-II/III-IV)
|
7.922 (4.739-13.242)
|
<0.001
|
3.292 (1.563-6.937)
|
0.002
|
|
Cirrhosis (absent/present)
|
0.999 (0.679-1.471)
|
0.996
| | |
|
TNM stage (I-II/III-IV)
|
23.349 (11.008-49.527)
|
<0.001
|
3.848 (1.494-9.915)
|
0.005
|
|
Tumor microsatellite (absent/present)
|
1.877 (1.216-2.896)
|
0.004
|
1.404 (0.392-5.030)
|
0.602
|
|
Portal vein tumor thrombus (absent/present)
|
46.801 (16.166-135.495)
|
<0.001
|
11.741 (3.503-39.355)
|
<0.001
|
|
Recurrence (absent/present)
|
2.739 (1.628-4.609)
|
<0.001
|
1.220 (0.645-2.308)
|
0.541
|
|
ANCCA expression (−/+/++)
|
10.275 (6.440-16.395)
|
<0.001
|
8.745 (4.936-15.493)
|
<0.001
|
